Microsoft Corporation

$ 414.44

1.63%

01 May - close price

  • Market Cap 3,076,820,566,000 USD
  • Current Price $ 414.44
  • High / Low $ 417.11 / 410.44
  • Stock P/E 24.68
  • Book Value 52.62
  • EPS 16.78
  • Next Earning Report -
  • Dividend Per Share $3.56
  • Dividend Yield 0.87 %
  • Next Dividend Date 2026-06-11
  • ROA 0.15 %
  • ROE 0.34 %
  • 52 Week High 552.24
  • 52 Week Low 356.28

About

Microsoft Corporation is an American multinational technology company which produces computer software, consumer electronics, personal computers, and related services. Its best known software products are the Microsoft Windows line of operating systems, the Microsoft Office suite, and the Internet Explorer and Edge web browsers. Its flagship hardware products are the Xbox video game consoles and the Microsoft Surface lineup of touchscreen personal computers. Microsoft ranked No. 21 in the 2020 Fortune 500 rankings of the largest United States corporations by total revenue; it was the world's largest software maker by revenue as of 2016. It is considered one of the Big Five companies in the U.S. information technology industry, along with Google, Apple, Amazon, and Facebook.

Analyst Target Price

$560.77

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-04-292026-01-282025-10-292025-07-302025-04-302025-01-292024-10-302024-07-302024-04-252024-01-302023-10-242023-07-25
Reported EPS 4.274.143.723.653.463.233.32.952.942.932.992.69
Estimated EPS 4.093.923.663.383.223.123.112.942.842.782.652.55
Surprise 0.180.220.060.270.240.110.190.010.10.150.340.14
Surprise Percentage 4.401%5.6122%1.6393%7.9882%7.4534%3.5256%6.1093%0.3401%3.5211%5.3957%12.8302%5.4902%

Next Quarterly Earnings

Reported Date
Fiscal Date Ending
Estimated EPS
Currency

Previous Dividend Records

Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Payment Date 2026-06-112026-03-122025-12-112025-09-112025-06-122025-03-132024-12-122024-09-122024-06-132024-03-14
Amount $0.91$0.91$0.91$0.83$0.83$0.83$0.83$0.75$0.75$0.75

Next Dividend Records

Dividend per share (year): $3.56
Dividend Yield 0.87%
Next Dividend Date 2026-06-11
Ex-Dividend Date 2026-05-21

Recent News: MSFT

...
Bridging the gap: Legacy tools gain enterprise AI support

2026-05-04 21:09:37

Major updates to legacy IT automation tools from Broadcom, BMC, and IBM are connecting agentic AI to critical enterprise systems like ERP and mainframes. These enhancements aim to integrate AI into existing workflows, offering deterministic orchestration and governance to improve reliability and security. The vendors are leveraging their established access to critical customer systems to position their updated tools as a trusted way to integrate AI, facilitating backward compatibility for enterprises with diverse IT infrastructures.

...
BMO Uses AI to Boost Business Banking Sales

2026-05-04 20:14:08

Bank of Montreal (BMO) is leveraging machine learning and Codat's technology to analyze customer payment and accounts-payable data. This initiative aims to provide salespeople with actionable recommendations, allowing them to serve as more informed financial advisors. A pilot program is expected to launch in Canada soon, with a broader rollout anticipated by the end of 2026.

...
Globe Life co-chairman & CEO Svoboda sells $1.54m in shares

2026-05-04 19:52:44

Globe Life Inc.'s Co-Chairman and CEO, Frank M. Svoboda, sold 10,000 shares of the company's common stock for approximately $1.54 million, following an exercise of employee stock options. The transactions occurred on May 1, 2026, near the stock's 52-week high, with Svoboda retaining over 54,000 direct shares. InvestingPro analysis suggests Globe Life is currently undervalued, with the stock trading at a P/E ratio of 10.54.

A Look At Crinetics Pharmaceuticals (CRNX) Valuation After PALSONIFY’s EU Approval And Global Expansion Progress

2026-05-04 19:39:46

Crinetics Pharmaceuticals (CRNX) recently received EU approval for PALSONIFY, its oral acromegaly treatment, enhancing its global reach. Despite recent share price declines, the company is considered 52.7% undervalued with a fair value of $82.43, suggesting significant growth potential from PALSONIFY's market expansion and growing preference for oral therapies. Investors are urged to examine specific assumptions and risks impacting this valuation.

...
Anchor Investment Management Offloads Over 1 Million BSCQ ETF Shares

2026-05-04 19:02:00

Anchor Investment Management, LLC has significantly reduced its holdings in the Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) by selling over 1 million shares, valued at approximately $21.1 million, during the first quarter of 2026. This divestment was a strategic move as the target maturity ETF approaches its December 2026 maturation date. The firm, primarily equity-focused, now holds a nominal position in BSCQ, with its portfolio dominated by tech and financial giants like Google, Microsoft, and Apple.

...
SAP Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Warehouse Management Systems

2026-05-04 16:50:50

SAP has been recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Warehouse Management Systems for the 12th consecutive time, underscoring its commitment to innovation in warehouse execution. The company's solutions, including SAP Extended Warehouse Management (SAP EWM) and the newly available SAP Logistics Management, cater to diverse warehouse needs and integrate with broader supply chain functions. This recognition reflects the trust customers place in SAP for managing complex and critical warehouse operations globally.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi